Oncology Biopharmaceuticals

OCEAN BIOMEDICAL INC C/WTS 14/02/2028 (TO PUR COM)

OPTIMI HEALTH CORP

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

HCW Biologics

Micware

Silexion Therapeutics

GCL Global

MetaVia

Vida Global

MicroAlgo

BiomX

OMEX

PICK

Odyssey Marine Exploration has signed a definitive merger agreement with American Ocean Minerals, which will involve a stock-for-stock deal and a name change to American Ocean Minerals. The transaction includes a $156 million PIPE and arrangements for bridge debentures and secured notes. The merger aims to create a combined deep-sea minerals company and is expected to close between late Q2 and early Q3 2026, pending approvals and financing conditions. Additionally, Odyssey plans to place its ORM assets into a liquidating trust for pre-close shareholders.

TradingView

Odyssey Marine

ISHRS MSCI Glb Slct Met & Mining

Odyssey Marine to Merge With American Ocean Minerals; Raises $156M PIPE, Sets Asset Spinoff

ARKG

OCEA

OCEAW

Ondine Study on ICU Nasal Photodisinfection Wins Acceptance in Journal of Critical Care

Tip Ranks

Ark Genomic Revolution ETF

Invesco Biotechnology & Genome ETF

Health Care Select Sector SPDR

Ocean Biomedical, Inc.

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

VG Health

Invesco Nasdaq Biotechnology ETF

Direxion S&P Biotech Bull 3X

iShares Biotechnology ETF

Proshares Ultra Nasdaq Biotech

VanEck Biotech ETF

Psyence Biomedical

CLEARSIDE BIOMEDICAL INC

SPDR S&P Biotech

Ondine Study on ICU Nasal Photodisinfection Wins Acceptance in Journal of Critical Care

Zaggle CFO Resigns; Board Names Interim Finance Chief

iShares US Pharma

iShares Global Healthcare

Zaggle CFO Resigns; Board Names Interim Finance Chief

Oceana Metals Options Lapse, Trimming Potential Share Dilution

Odin Metals Ltd

Oceana Metals Options Lapse, Trimming Potential Share Dilution

Oceana Metals Seeks ASX Quotation for Nearly 295,000 New Shares

Oceana Metals Seeks ASX Quotation for Nearly 295,000 New Shares

M&G Plc has notified a change in its holdings in Ondine Biomedical Inc., crossing the 13% threshold with a current holding of 13.0419% of voting rights. This change was reported on February 12, 2026, after the threshold was reached on February 11, 2026. The notification includes details of the voting rights held directly and indirectly by M&G Plc and its subsidiaries.

London Stock Exchange

M&G Plc

REG - Ondine Biomedical M&G PLC - Holding(s) in Company

Ondine Biomedical (LON:OBI) shares hit a new 52-week low of C$7.50, last trading at C$8.00 with a volume of 89,210 shares. The stock's 50-day moving average is C$9.79, and the 200-day moving average is C$12.56. The company has a market cap of C$4.15 billion and a price-to-earnings ratio of -1.14. Analysts currently rate the stock as a Hold, but it is not among the top recommended stocks by analysts.

Market Beat

Direxion S&P Biotech Bear 3X

Oncolytics Biotech

Ondine Biomedical (LON:OBI) Sets New 12-Month Low  - Here's What Happened

OCEAN BIOMEDICAL INC C/WTS 14/02/2028 (TO PUR COM)(OCEAW.US)

Odyssey Marine to Merge With American Ocean Minerals; Raises $156M PIPE, Sets Asset Spinoff

Ondine Study on ICU Nasal Photodisinfection Wins Acceptance in Journal of Critical Care

Zaggle CFO Resigns; Board Names Interim Finance Chief

Oceana Metals Options Lapse, Trimming Potential Share Dilution

Oceana Metals Seeks ASX Quotation for Nearly 295,000 New Shares

REG - Ondine Biomedical M&G PLC - Holding(s) in Company

Ondine Biomedical (LON:OBI) Sets New 12-Month Low - Here's What Happened